Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle

被引:40
|
作者
Ekblad, E
Sundler, F
机构
[1] Dept. of Physiology and Neuroscience, Sect. Neuroendocrine Cellbiology, U.
关键词
PACAP (pituitary adenylate cyclase-activating peptide); VIP (vasoactive intestinal peptide); PACAP receptor; VIP receptor; neuropeptide Y; motor effect; gastro-intestinal tract; apamin;
D O I
10.1016/S0014-2999(97)01144-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Relaxant responses to pituitary adenylate cyclase-activating peptide (PACAP)-27, PACAP-38 and vasoactive intestinal peptide (VIP) were examined in rat ileal longitudinal muscle. PACAP-27 was much more potent than PACAP-38 and VIP, with PACAP-38 and VIP being equipotent. The relaxation induced by each of the peptides was unaffected by pretreatment with NG-nitro-L-arginine methyl ester (L-NAME) (10(-4) M), tetrodotoxin (10(-6) M) or atropine (10(-6) M). Pretreatment with apamin (10(-6) M) abolished the relaxations induced by PACAP-27, but not those induced by PACAP-38 or VIP. Pretreatment with neuropeptide Y (NPY) (10(-7) M) inhibited relaxations induced by VIP, but not those induced by PACAP-27 or PACAP-38. No cross-desensitization between PACAP-27 and VIP could be revealed. In conclusion, distinct receptors mediate PACAP- and VIP-induced relaxations of rat ileal longitudinal muscle. At least three different types of receptors may exist: (1) a PACAP-27 preferring receptor coupled to apamin sensitive Ca2+-dependent K+ channels, (2) a PACAP specific receptor activated by both PACAP-27 and PACAP-38 but not by VIP and (3) a VIP specific receptor regulated by NPY by yet unknown mechanisms. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 50 条
  • [31] PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP), A NEW VASOACTIVE-INTESTINAL-PEPTIDE (VIP)-LIKE PEPTIDE IN THE RESPIRATORY-TRACT
    UDDMAN, R
    LUTS, A
    ARIMURA, A
    SUNDLER, F
    CELL AND TISSUE RESEARCH, 1991, 265 (01) : 197 - 201
  • [32] Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity
    Onoue, S
    Endo, K
    Yajima, T
    Kashimoto, K
    REGULATORY PEPTIDES, 2002, 107 (1-3) : 43 - 47
  • [33] Estrogens impair hypophagia and hypothalamic cell activation induced by vasoactive intestinal peptide, but not by pituitary adenylate cyclase-activating polypeptide
    Garnica-Siqueira, Marcela Cristina
    Martins, Andressa Busetti
    Monteiro, Erica Cristina Alves Munhoz
    de Oliveira, Maria Heloisa Bernardes
    Baratto, Carolina dos Reis
    Tsutsui, Fabiano Takeo Komay
    de Oliveira, Lucas Leonardo Franca
    Stopa, Larissa Rugila dos Santos
    de Souza, Camila Franciele
    Wunderlich, Ana Luiza Machado
    Zaia, Dimas Augusto Morozin
    Leite, Cristiane Mota
    Zaia, Cassia Thais Bussamra Vieira
    Uchoa, Ernane Torres
    PEPTIDES, 2025, 183
  • [34] Interactive mechanisms among pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide, and parathyroid hormone receptors in guinea pig cecal circular smooth muscle cells
    Motomura, Y
    Chijiiwa, Y
    Iwakiri, Y
    Ochiai, T
    Nawata, H
    ENDOCRINOLOGY, 1998, 139 (06) : 2869 - 2878
  • [35] Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors
    Bokaei, Payman Baradar
    Ma, Xue-Zhong
    Byczynski, Bartosz
    Keller, Jeremy
    Sakac, Darinka
    Fahim, Soad
    Branch, Donald R.
    GENOMICS, 2006, 88 (06) : 791 - 800
  • [36] International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
    Harmar, AJ
    Arimura, A
    Gozes, I
    Journot, L
    Laburthe, M
    Pisegna, JR
    Rawlings, SR
    Robberecht, P
    Said, SI
    Sreedharan, SP
    Wank, SA
    Waschek, JA
    PHARMACOLOGICAL REVIEWS, 1998, 50 (02) : 265 - 270
  • [37] Effects of pituitary adenylate cyclase-activating peptide on testicular microcirculation of the rat
    Lissbrant, E
    Bergh, A
    JOURNAL OF VASCULAR RESEARCH, 1998, 35 : 46 - 46
  • [38] PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) MIMICS THE ACTIONS OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP) ON GASTRIC CHIEF CELLS
    RAUFMAN, JP
    SINGH, L
    CLINICAL RESEARCH, 1992, 40 (02): : A262 - A262
  • [39] Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide
    Katsoulis, S
    Schmidt, WE
    Schwarzhoff, R
    Folsch, UR
    Jin, JG
    Grider, JR
    Makhlouf, GM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 278 (01): : 199 - 204
  • [40] Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons
    Drahushuk, K
    Connell, TD
    Higgins, D
    JOURNAL OF NEUROSCIENCE, 2002, 22 (15): : 6560 - 6569